Distribution of a New Presentation of SPIKEVAX (elasomeran) COVID-19 Vaccine (0.10 mg/mL in 2.5 mL multidose vial) with English-only Vial and Carton Labels

A new presentation of SPIKEVAX (elasomeran) with a concentration of 0.1 0 mg/mL in a 2.5 mL multidose vial was authorized on June 01, 2022. In order to provide rapid access to the new presentation of SPIKEVAX (0.1 0 mg/mL, 2.5 mL multidose vial), Moderna will distribute vaccine product with English-only carton and vial labels for a period of time. As a result, important Canadian-specific information is absent from these labels (see the Information for healthcare professionals section).

Labelling - Packaging - Product safety - COVID

SPIKEVAX (elasomeran) (0.10 mg/mL)

RA-64229